Skip to main content

Boston Scientific balance sheet

  • BSX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$44.34+0.32%Close 13 Nov 2026 · Market value $63.59B

At the end of fiscal 2025 (the year to 31 Dec 2025), Boston Scientific reported total assets of $43.67B, $1.97B in cash and equivalents, $11.97B of total debt; shareholders' equity was $24.23B.

From Boston Scientific's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Boston Scientific balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$1.45B$1.64B$864.0M$213.0M$267.0M$207.0M$217.0M$587.0M$319.0M$196.0M$188.0M$146.0M$217.0M$1.73B$1.93B$928.0M$865.0M$414.0M$1.97B
Cash and short-term investments$1.45B$1.64B$864.0M$213.0M$267.0M$207.0M$217.0M$587.0M$319.0M$196.0M$188.0M$146.0M$217.0M$1.73B$1.93B$928.0M$865.0M$414.0M$1.97B
Inventory—$853.0M$891.0M$894.0M$931.0M$884.0M$897.0M$946.0M$1.02B$955.0M$1.08B$1.17B$1.58B$1.35B$1.61B$1.87B$2.48B$2.81B$2.94B
Current assets—$5.45B$4.60B$3.62B$3.10B$3.02B$3.01B$3.61B$3.47B$3.24B$3.82B$4.00B$4.70B$6.69B$6.32B$5.76B$6.51B$6.92B$8.79B
Property, plant and equipment—$1.73B$1.72B$1.70B$1.67B$1.56B$1.55B$1.51B$1.49B$1.63B$1.70B$1.78B$2.08B$2.08B$2.25B$2.45B$2.86B$3.29B$4.04B
Goodwill—$12.42B$11.94B$10.19B$9.76B$5.97B$5.69B$5.90B$6.47B$6.68B$7.00B$7.91B$10.18B$9.95B$11.99B$12.92B$14.39B$17.09B$18.28B
Acquired intangibles—$7.24B$6.67B$6.34B$6.47B$6.29B$5.95B$5.61B$6.19B$5.88B$5.84B$6.37B$7.89B$5.92B$6.12B$5.90B$6.00B$6.68B$7.02B
Total assets—$27.14B$25.18B$22.13B$21.29B$17.15B$16.57B$17.02B$18.13B$18.10B$19.04B$21.00B$30.57B$30.78B$32.23B$32.47B$35.14B$39.40B$43.67B
Accounts payable—$239.0M$212.0M$184.0M$203.0M$232.0M$246.0M$262.0M$209.0M$447.0M$530.0M$349.0M$542.0M$513.0M$794.0M$862.0M$942.0M$960.0M$1.14B
Unearned revenue, current———————————$115.0M$144.0M$138.0M$208.0M$220.0M$266.0M$306.0M$313.0M
Long-term debt · current portion—$2.00M$3.00M$504.0M$4.00M$4.00M$0.00$400.0M$0.00$250.0M$1.80B$2.25B$1.42B$13.00M$261.0M$20.00M$531.0M$1.78B$299.0M
Current liabilities—$3.23B$3.02B$2.61B$1.81B$1.77B$1.82B$2.85B$2.43B$3.59B$5.65B$5.26B$4.87B$3.68B$4.27B$3.80B$4.93B$6.40B$5.44B
Long-term debt · non-current—$6.74B$5.92B$4.93B$4.26B$4.25B$4.24B$3.84B$5.67B$5.42B$3.81B$4.80B$8.59B$9.13B$8.80B$8.91B$8.57B$8.97B$11.14B
Operating lease liability————————————$343.0M—$460.0M$408.0M$466.0M$482.0M$536.0M
Total liabilities—$13.96B$12.88B$10.83B$9.94B$10.28B$10.03B$10.57B$11.81B$11.36B$12.03B$12.27B$16.69B$15.45B$15.61B$14.90B$15.61B$17.39B$19.20B
Retained earnings—−$2.73B−$3.76B−$4.82B−$4.38B−$8.45B−$8.57B−$8.69B−$8.93B−$8.58B−$8.39B−$6.95B−$2.25B−$2.38B−$1.39B−$750.0M$819.0M$2.67B$5.57B
Minority interest———————————————$0.00$248.0M$233.0M$239.0M
Shareholders' equity—$13.17B$12.30B$11.30B$11.35B$6.87B$6.54B$6.46B$6.32B$6.73B$7.01B$8.73B$13.88B$15.33B$16.62B$17.57B$19.28B$21.77B$24.23B
Total liabilities and equity—$27.14B$25.18B$22.13B$21.29B$17.15B$16.57B$17.02B$18.13B$18.10B$19.04B$21.00B$30.57B$30.78B$32.23B$32.47B$35.14B$39.40B$43.67B
Total debt—$6.75B$5.92B$5.44B$4.26B$4.26B$4.24B$4.24B$5.67B$5.67B$5.62B$7.06B$10.35B$9.54B$9.53B$9.34B$9.57B$11.23B$11.97B
Net debt—$5.10B$5.05B$5.22B$3.99B$4.05B$4.02B$3.65B$5.36B$5.47B$5.43B$6.91B$10.13B$7.81B$7.60B$8.41B$8.70B$10.81B$10.01B
Net working capital—$578.0M$713.0M$793.0M$1.03B$1.04B$970.0M$173.0M$722.0M−$544.0M−$2.02B−$1.40B−$384.0M$1.28B$118.0M$1.03B$716.0M$107.0M$1.39B
Shares outstanding · period end——1.5B1.5B1.4B1.4B1.3B1.3B1.3B1.4B1.4B1.4B1.4B1.4B1.4B1.4B1.5B1.5B1.5B

Quarterly

Boston Scientific balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$865.0M$2.33B$2.91B$2.50B$414.0M$725.0M$534.0M$1.27B$1.97B$1.45B$539.0M$609.0M
Cash and short-term investments$865.0M$2.33B$2.91B$2.50B$414.0M$725.0M$534.0M$1.27B$1.97B$1.45B$539.0M$609.0M
Inventory$2.48B$2.56B$2.61B$2.75B$2.81B$2.87B$2.86B$2.92B$2.94B$3.12B$3.23B$3.32B
Current assets$6.51B$8.19B$8.99B$8.76B$6.92B$7.33B$7.12B$8.04B$8.79B$8.68B$7.97B$8.16B
Property, plant and equipment$2.86B$2.90B$2.95B$3.07B$3.29B$3.39B$3.46B$3.79B$4.04B$4.06B$4.13B$4.18B
Goodwill$14.39B$14.36B$14.40B$15.03B$17.09B$17.34B$18.08B$18.21B$18.28B$18.54B$18.64B$18.74B
Acquired intangibles$6.00B$5.84B$5.42B$5.75B$6.68B$6.57B$7.26B$7.16B$7.02B$7.06B$6.92B$6.86B
Total assets$35.14B$36.67B$37.11B$38.08B$39.40B$40.14B$41.56B$42.71B$43.67B$44.35B$45.22B$45.46B
Accounts payable$942.0M$921.0M$906.0M$907.0M$960.0M$1.00B$962.0M$1.00B$1.14B$1.14B$1.23B$1.25B
Unearned revenue, current$266.0M$280.0M$284.0M$290.0M$306.0M$306.0M$313.0M$309.0M$313.0M———
Long-term debt · current portion$531.0M$1.08B$1.58B$1.65B$1.78B$777.0M$480.0M$483.0M$299.0M$41.00M$1.71B$1.04B
Current liabilities$4.93B$4.92B$5.58B$5.91B$6.40B$5.06B$5.19B$5.33B$5.44B$4.57B$6.43B$5.98B
Long-term debt · non-current$8.57B$9.53B$8.99B$9.23B$8.97B$10.53B$11.11B$11.12B$11.14B$10.99B$10.91B$10.91B
Operating lease liability$466.0M———$482.0M———$536.0M———
Finance lease liability———————$195.0M————
Total liabilities$15.61B$16.50B$16.50B$17.12B$17.39B$17.70B$18.91B$19.08B$19.20B$18.25B$20.04B$19.59B
Retained earnings$819.0M$1.31B$1.64B$2.11B$2.67B$3.35B$4.14B$4.90B$5.57B$6.91B$7.82B$8.40B
Minority interest$248.0M$242.0M$238.0M$248.0M$233.0M$233.0M$235.0M$236.0M$239.0M$240.0M$242.0M$243.0M
Shareholders' equity$19.28B$19.93B$20.37B$20.71B$21.77B$22.21B$22.42B$23.39B$24.23B$25.86B$24.93B$25.63B
Total liabilities and equity$35.14B$36.67B$37.11B$38.08B$39.40B$40.14B$41.56B$42.71B$43.67B$44.35B$45.22B$45.46B
Total debt$9.57B$11.00B$10.94B$11.26B$11.23B$11.71B$12.03B$12.04B$11.97B$11.03B$12.62B$11.95B
Net debt$8.70B$8.67B$8.02B$8.76B$10.81B$10.98B$11.49B$10.77B$10.01B$9.58B$12.09B$11.34B
Net working capital$716.0M$940.0M$502.0M$349.0M$107.0M$1.55B$1.40B$1.43B$1.39B$2.66B$1.00B$1.57B
Shares outstanding · period end1.5B1.5B1.5B1.5B1.5B1.5B1.5B1.5B1.5B1.5B1.4B1.4B

The main figures as JSON and plain text. See data and methodology.

BSX in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.